ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prostate Cancer Therapeutics Market Insights, Forecast to 2028
Published Date: 2022-03-08
|
Report Code: QYRE-Auto-2S6428
Home | Market Reports
Global Prostate Cancer Therapeutics Market Insights Forecast to 2028

Global Prostate Cancer Therapeutics Market Insights, Forecast to 2028

Code: QYRE-Auto-2S6428
Report
2022-03-08
Pages:109
QYResearch
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Prostate Cancer Therapeutics Market

The global Prostate Cancer Therapeutics market size is projected to reach US$ 9677.3 million by 2028, from US$ 7420 million in 2021, at a CAGR of 3.8% during 2022-2028.

Fully considering the economic change by this health crisis, Drugs accounting for % of the Prostate Cancer Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Prostate Cancer Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Prostate Cancer Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Prostate Cancer Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Therapeutics market.
Global Prostate Cancer Therapeutics Scope and Market Size
Prostate Cancer Therapeutics market is segmented by players, region (country), by Type and by Sale Channel. Players, stakeholders, and other participants in the global Prostate Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Sale Channel for the period 2017-2028.

Segment by Type

Drugs
Medical Devices
Segment by Sale Channel
Hospital Pharmacy
Retail Pharmacy
Online Sales

BY COMPANY

Sanofi
Pfizer
Amgen
Johnson & Johnson
AstraZeneca
AbbVie
Bayer
Ipsen Group
Endo Pharmaceuticals
Dendreon Corporation(Sanpower Group Co. Ltd.)

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drugs
1.2.3 Medical Devices
1.3 Market by Sale Channel
1.3.1 Global Prostate Cancer Therapeutics Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Therapeutics Market Perspective (2017-2028)
2.2 Prostate Cancer Therapeutics Growth Trends by Region
2.2.1 Prostate Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Prostate Cancer Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Prostate Cancer Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Prostate Cancer Therapeutics Market Dynamics
2.3.1 Prostate Cancer Therapeutics Industry Trends
2.3.2 Prostate Cancer Therapeutics Market Drivers
2.3.3 Prostate Cancer Therapeutics Market Challenges
2.3.4 Prostate Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Therapeutics Players by Revenue
3.1.1 Global Top Prostate Cancer Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Prostate Cancer Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Prostate Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Therapeutics Revenue
3.4 Global Prostate Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Prostate Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Revenue in 2021
3.5 Prostate Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Prostate Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Therapeutics Breakdown Data by Type
4.1 Global Prostate Cancer Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2023-2028)
5 Prostate Cancer Therapeutics Breakdown Data by Sale Channel
5.1 Global Prostate Cancer Therapeutics Historic Market Size by Sale Channel (2017-2022)
5.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Sale Channel (2023-2028)
6 North America
6.1 North America Prostate Cancer Therapeutics Market Size (2017-2028)
6.2 North America Prostate Cancer Therapeutics Market Size by Type
6.2.1 North America Prostate Cancer Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Prostate Cancer Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Prostate Cancer Therapeutics Market Share by Type (2017-2028)
6.3 North America Prostate Cancer Therapeutics Market Size by Sale Channel
6.3.1 North America Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022)
6.3.2 North America Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028)
6.3.3 North America Prostate Cancer Therapeutics Market Share by Sale Channel (2017-2028)
6.4 North America Prostate Cancer Therapeutics Market Size by Country
6.4.1 North America Prostate Cancer Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Prostate Cancer Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Prostate Cancer Therapeutics Market Size (2017-2028)
7.2 Europe Prostate Cancer Therapeutics Market Size by Type
7.2.1 Europe Prostate Cancer Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Prostate Cancer Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Prostate Cancer Therapeutics Market Share by Type (2017-2028)
7.3 Europe Prostate Cancer Therapeutics Market Size by Sale Channel
7.3.1 Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022)
7.3.2 Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028)
7.3.3 Europe Prostate Cancer Therapeutics Market Share by Sale Channel (2017-2028)
7.4 Europe Prostate Cancer Therapeutics Market Size by Country
7.4.1 Europe Prostate Cancer Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Prostate Cancer Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Prostate Cancer Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Prostate Cancer Therapeutics Market Size by Sale Channel
8.3.1 Asia-Pacific Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022)
8.3.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028)
8.3.3 Asia-Pacific Prostate Cancer Therapeutics Market Share by Sale Channel (2017-2028)
8.4 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Cancer Therapeutics Market Size (2017-2028)
9.2 Latin America Prostate Cancer Therapeutics Market Size by Type
9.2.1 Latin America Prostate Cancer Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Prostate Cancer Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Prostate Cancer Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Prostate Cancer Therapeutics Market Size by Sale Channel
9.3.1 Latin America Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022)
9.3.2 Latin America Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028)
9.3.3 Latin America Prostate Cancer Therapeutics Market Share by Sale Channel (2017-2028)
9.4 Latin America Prostate Cancer Therapeutics Market Size by Country
9.4.1 Latin America Prostate Cancer Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Prostate Cancer Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Prostate Cancer Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel
10.3.1 Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022)
10.3.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028)
10.3.3 Middle East & Africa Prostate Cancer Therapeutics Market Share by Sale Channel (2017-2028)
10.4 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Prostate Cancer Therapeutics Introduction
11.1.4 Sanofi Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Prostate Cancer Therapeutics Introduction
11.2.4 Pfizer Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Prostate Cancer Therapeutics Introduction
11.3.4 Amgen Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.3.5 Amgen Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Prostate Cancer Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Prostate Cancer Therapeutics Introduction
11.5.4 AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.5.5 AstraZeneca Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Prostate Cancer Therapeutics Introduction
11.6.4 AbbVie Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.6.5 AbbVie Recent Developments
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Prostate Cancer Therapeutics Introduction
11.7.4 Bayer Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.7.5 Bayer Recent Developments
11.8 Ipsen Group
11.8.1 Ipsen Group Company Details
11.8.2 Ipsen Group Business Overview
11.8.3 Ipsen Group Prostate Cancer Therapeutics Introduction
11.8.4 Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.8.5 Ipsen Group Recent Developments
11.9 Endo Pharmaceuticals
11.9.1 Endo Pharmaceuticals Company Details
11.9.2 Endo Pharmaceuticals Business Overview
11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Introduction
11.9.4 Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.9.5 Endo Pharmaceuticals Recent Developments
11.10 Dendreon Corporation(Sanpower Group Co. Ltd.)
11.10.1 Dendreon Corporation(Sanpower Group Co. Ltd.) Company Details
11.10.2 Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview
11.10.3 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Introduction
11.10.4 Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2017-2022)
11.10.5 Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Prostate Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Drugs
    Table 3. Key Players of Medical Devices
    Table 4. Global Prostate Cancer Therapeutics Market Size Growth Rate by Sale Channel (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Prostate Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Prostate Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Prostate Cancer Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Prostate Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Prostate Cancer Therapeutics Market Share by Region (2023-2028)
    Table 10. Prostate Cancer Therapeutics Market Trends
    Table 11. Prostate Cancer Therapeutics Market Drivers
    Table 12. Prostate Cancer Therapeutics Market Challenges
    Table 13. Prostate Cancer Therapeutics Market Restraints
    Table 14. Global Prostate Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Prostate Cancer Therapeutics Revenue Share by Players (2017-2022)
    Table 16. Global Top Prostate Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics as of 2021)
    Table 17. Ranking of Global Top Prostate Cancer Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Prostate Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Prostate Cancer Therapeutics Product Solution and Service
    Table 21. Date of Enter into Prostate Cancer Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prostate Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & (US$ Million)
    Table 28. Global Prostate Cancer Therapeutics Revenue Share by Sale Channel (2017-2022)
    Table 29. Global Prostate Cancer Therapeutics Forecasted Market Size by Sale Channel (2023-2028) & (US$ Million)
    Table 30. Global Prostate Cancer Therapeutics Revenue Share by Sale Channel (2023-2028)
    Table 31. North America Prostate Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Prostate Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & (US$ Million)
    Table 34. North America Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028) & (US$ Million)
    Table 35. North America Prostate Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Prostate Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Prostate Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Prostate Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & (US$ Million)
    Table 40. Europe Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028) & (US$ Million)
    Table 41. Europe Prostate Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Prostate Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Prostate Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Prostate Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Prostate Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Prostate Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Prostate Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Prostate Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & (US$ Million)
    Table 52. Latin America Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028) & (US$ Million)
    Table 53. Latin America Prostate Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Prostate Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Prostate Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Prostate Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Prostate Cancer Therapeutics Market Size by Sale Channel (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Prostate Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Prostate Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Sanofi Company Details
    Table 62. Sanofi Business Overview
    Table 63. Sanofi Prostate Cancer Therapeutics Product
    Table 64. Sanofi Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Sanofi Recent Developments
    Table 66. Pfizer Company Details
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Prostate Cancer Therapeutics Product
    Table 69. Pfizer Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Pfizer Recent Developments
    Table 71. Amgen Company Details
    Table 72. Amgen Business Overview
    Table 73. Amgen Prostate Cancer Therapeutics Product
    Table 74. Amgen Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Amgen Recent Developments
    Table 76. Johnson & Johnson Company Details
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Prostate Cancer Therapeutics Product
    Table 79. Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Johnson & Johnson Recent Developments
    Table 81. AstraZeneca Company Details
    Table 82. AstraZeneca Business Overview
    Table 83. AstraZeneca Prostate Cancer Therapeutics Product
    Table 84. AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. AstraZeneca Recent Developments
    Table 86. AbbVie Company Details
    Table 87. AbbVie Business Overview
    Table 88. AbbVie Prostate Cancer Therapeutics Product
    Table 89. AbbVie Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. AbbVie Recent Developments
    Table 91. Bayer Company Details
    Table 92. Bayer Business Overview
    Table 93. Bayer Prostate Cancer Therapeutics Product
    Table 94. Bayer Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 95. Bayer Recent Developments
    Table 96. Ipsen Group Company Details
    Table 97. Ipsen Group Business Overview
    Table 98. Ipsen Group Prostate Cancer Therapeutics Product
    Table 99. Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. Ipsen Group Recent Developments
    Table 101. Endo Pharmaceuticals Company Details
    Table 102. Endo Pharmaceuticals Business Overview
    Table 103. Endo Pharmaceuticals Prostate Cancer Therapeutics Product
    Table 104. Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 105. Endo Pharmaceuticals Recent Developments
    Table 106. Dendreon Corporation(Sanpower Group Co. Ltd.) Company Details
    Table 107. Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview
    Table 108. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product
    Table 109. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 110. Dendreon Corporation(Sanpower Group Co. Ltd.) Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Drugs Features
    Figure 3. Medical Devices Features
    Figure 4. Global Prostate Cancer Therapeutics Market Share by Sale Channel: 2021 VS 2028
    Figure 5. Hospital Pharmacy Case Studies
    Figure 6. Retail Pharmacy Case Studies
    Figure 7. Online Sales Case Studies
    Figure 8. Prostate Cancer Therapeutics Report Years Considered
    Figure 9. Global Prostate Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Prostate Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Prostate Cancer Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Prostate Cancer Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Prostate Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Therapeutics Revenue in 2021
    Figure 15. North America Prostate Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 17. North America Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2028)
    Figure 18. North America Prostate Cancer Therapeutics Market Size Share by Country (2017-2028)
    Figure 19. United States Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Prostate Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2028)
    Figure 24. Europe Prostate Cancer Therapeutics Market Size Share by Country (2017-2028)
    Figure 25. Germany Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Prostate Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2028)
    Figure 34. Asia Pacific Prostate Cancer Therapeutics Market Size Share by Region (2017-2028)
    Figure 35. China Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Prostate Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2028)
    Figure 44. Latin America Prostate Cancer Therapeutics Market Size Share by Country (2017-2028)
    Figure 45. Mexico Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Prostate Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Prostate Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Prostate Cancer Therapeutics Market Size Market Share by Sale Channel (2017-2028)
    Figure 50. Middle East and Africa Prostate Cancer Therapeutics Market Size Share by Country (2017-2028)
    Figure 51. Turkey Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Prostate Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Sanofi Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 55. Pfizer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 56. Amgen Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 58. AstraZeneca Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 59. AbbVie Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 60. Bayer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 61. Ipsen Group Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 62. Endo Pharmaceuticals Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 63. Dendreon Corporation(Sanpower Group Co. Ltd.) Revenue Growth Rate in Prostate Cancer Therapeutics Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
INQUIRE FOR DISCOUNT
HAVE A QUERY?
INQUIRE ABOUT REPORT EMAIL US
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICIES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions